Doxorubicin-Induced Cardiomyopathy
10.1016/j.pcad.2006.10.002
Crossref journal-article
Elsevier BV
Progress in Cardiovascular Diseases (78)
Bibliography

Takemura, G., & Fujiwara, H. (2007). Doxorubicin-Induced Cardiomyopathy. Progress in Cardiovascular Diseases, 49(5), 330–352.

Authors 2
  1. Genzou Takemura (first)
  2. Hisayoshi Fujiwara (additional)
References 186 Referenced 677
  1. {'key': '10.1016/j.pcad.2006.10.002_bib1', 'first-page': '670', 'article-title': 'The anthracyclines: Will we ever find a better doxorubicin?', 'volume': '19', 'author': 'Weiss', 'year': '1992', 'journal-title': 'Semin. Oncol.'} / Semin. Oncol. / The anthracyclines: Will we ever find a better doxorubicin? by Weiss (1992)
  2. 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2 / Cancer / A clinicopathologic analysis of adriamycin cardiotoxicity by Lefrak (1973)
  3. 10.1002/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO;2-6 / Cancer / The cardiotoxicity of adriamycin and daunomycin in children by Gilladoga (1976)
  4. 10.1016/0002-9343(78)90802-1 / Am. J. Med. / Early anthracycline cardiotoxicity by Bristow (1978)
  5. 10.7326/0003-4819-91-5-710 / Ann. Intern. Med. / Risk factors for doxorubicin-induced congestive heart failure by Von Hoff (1979)
  6. 10.1016/S0006-2952(98)00307-4 / Biochem. Pharmacol. / A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin by Gewirtz (1999)
  7. 10.1124/pr.56.2.6 / Pharmacol. Rev. / Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity by Minotti (2004)
  8. {'key': '10.1016/j.pcad.2006.10.002_bib8', 'first-page': '1078', 'article-title': 'Nuclear catalyzed antibiotic free radical formation', 'volume': '42', 'author': 'Bachur', 'year': '1982', 'journal-title': 'Cancer Res.'} / Cancer Res. / Nuclear catalyzed antibiotic free radical formation by Bachur (1982)
  9. 10.1016/0006-2952(87)90164-X / Biochem. Pharmacol. / Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells by Sinha (1987)
  10. 10.1021/bi00387a006 / Biochemistry / Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action by Sinha (1987)
  11. 10.1016/0006-2952(84)90069-8 / Biochem. Pharmacol. / Two mechanisms of adriamycin-DNA interaction in L1210 cells by Potmesil (1984)
  12. 10.1016/0014-5793(84)81130-8 / FEBS Lett. / Hydroxyl radical production and DNA damage induced by anthracycline-iron complex by Muindi (1984)
  13. {'key': '10.1016/j.pcad.2006.10.002_bib13', 'first-page': '356', 'article-title': 'Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms', 'volume': '27', 'author': 'Muindi', 'year': '1985', 'journal-title': 'Mol. Pharmacol.'} / Mol. Pharmacol. / Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms by Muindi (1985)
  14. 10.1021/bi00300a021 / Biochemistry / Oxidative destruction of DNA by the adriamycin-iron complex by Eliot (1984)
  15. 10.1016/0891-5849(94)00209-3 / Free Radic. Biol. Med. / Reactions of oxyl radicals with DNA by Breen (1995)
  16. 10.1016/0022-2828(95)90074-8 / J. Mol. Cell. Cardiol. / Combination therapy with probucol prevents adriamycin-induced cardiomyopathy by Singal (1995)
  17. 10.1093/ajcn/54.6.1298s / Am. J. Clin. Nutr. / Ascorbic acid and adriamycin toxicity by Shimpo (1991)
  18. 10.1016/0304-3835(88)90113-9 / Cancer Lett. / The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells by Cervantes (1988)
  19. 10.1126/science.877547 / Science / Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response by Myers (1977)
  20. {'key': '10.1016/j.pcad.2006.10.002_bib20', 'first-page': '53', 'article-title': 'A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine', 'volume': '10', 'author': 'Myers', 'year': '1983', 'journal-title': 'Semin. Oncol.'} / Semin. Oncol. / A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine by Myers (1983)
  21. {'key': '10.1016/j.pcad.2006.10.002_bib21', 'first-page': '2551', 'article-title': 'Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione', 'volume': '46', 'author': 'Yoda', 'year': '1986', 'journal-title': 'Cancer Res.'} / Cancer Res. / Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione by Yoda (1986)
  22. 10.1161/01.CIR.91.1.10 / Circulation / Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect by Siveski-Iliskovic (1995)
  23. 10.1016/0009-2797(79)90170-4 / Chem. Biol. Interact. / Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA by Sinha (1979)
  24. 10.1021/bi00285a033 / Biochemistry / Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid by Graves (1983)
  25. 10.1128/MCB.9.1.159 / Mol. Cell. Biol. / DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage by Holm (1989)
  26. 10.1016/0009-2797(89)90022-7 / Chem. Biol. Interact. / Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cells by Capranico (1989)
  27. 10.1016/0006-2952(93)90512-U / Biochem. Pharmacol. / Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells by Skladanowski (1993)
  28. 10.1016/0304-3835(94)03617-R / Cancer Lett. / Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamycin by Anand (1995)
  29. {'key': '10.1016/j.pcad.2006.10.002_bib29', 'first-page': '601', 'article-title': 'Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats', 'volume': '75', 'author': 'Cece', 'year': '1996', 'journal-title': 'Lab. Invest.'} / Lab. Invest. / Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats by Cece (1996)
  30. 10.1006/jmcc.1996.0186 / J. Mol. Cell. Cardiol. / Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187 by Zhang (1996)
  31. {'key': '10.1016/j.pcad.2006.10.002_bib31', 'first-page': '865', 'article-title': 'Anthracycline cardiomyopathy monitored by morphologic changes', 'volume': '62', 'author': 'Billingham', 'year': '1978', 'journal-title': 'Cancer. Treat. Rep.'} / Cancer. Treat. Rep. / Anthracycline cardiomyopathy monitored by morphologic changes by Billingham (1978)
  32. 10.1002/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO;2-A / Cancer / Cardiac ultrastructural changes induced by daunorubicin therapy by Buja (1973)
  33. {'key': '10.1016/j.pcad.2006.10.002_bib33', 'first-page': '873', 'article-title': 'Clinical spectrum of anthracycline antibiotic cardiotoxicity', 'volume': '62', 'author': 'Bristow', 'year': '1978', 'journal-title': 'Cancer Treat. Rep.'} / Cancer Treat. Rep. / Clinical spectrum of anthracycline antibiotic cardiotoxicity by Bristow (1978)
  34. 10.1097/00000478-197701010-00002 / Am. J. Surg. Pathol. / Adriamycin cardiotoxicity: Endomyocardial biopsy evidence of enhancement by irradiation by Billingham (1977)
  35. 10.1023/A:1007094214460 / Mol. Cell. Biochem. / Adriamycin-induced heart failure: Mechanism and modulation by Singal (2000)
  36. 10.1016/S0022-2828(87)80392-9 / J. Mol. Cell. Cardiol. / Subcellular effects of adriamycin in the heart: A concise review by Singal (1987)
  37. 10.1016/0304-4165(80)90142-7 / Biochim. Biophys. Acta. / Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs by Kalyanaraman (1980)
  38. {'key': '10.1016/j.pcad.2006.10.002_bib38', 'first-page': '460', 'article-title': 'Effect of anthracycline antibiotics on oxygen radical formation in rat heart', 'volume': '43', 'author': 'Doroshow', 'year': '1983', 'journal-title': 'Cancer Res.'} / Cancer Res. / Effect of anthracycline antibiotics on oxygen radical formation in rat heart by Doroshow (1983)
  39. {'key': '10.1016/j.pcad.2006.10.002_bib39', 'first-page': '139', 'article-title': 'Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy', 'volume': '1', 'author': 'Singal', 'year': '1985', 'journal-title': 'Can. J. Cardiol.'} / Can. J. Cardiol. / Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy by Singal (1985)
  40. {'key': '10.1016/j.pcad.2006.10.002_bib40', 'first-page': '285', 'article-title': 'The effect of doxorubicin on hepatic and cardiac glutathione', 'volume': '26', 'author': 'Doroshow', 'year': '1979', 'journal-title': 'Res. Commun. Chem. Pathol. Pharmacol.'} / Res. Commun. Chem. Pathol. Pharmacol. / The effect of doxorubicin on hepatic and cardiac glutathione by Doroshow (1979)
  41. {'key': '10.1016/j.pcad.2006.10.002_bib41', 'first-page': '450', 'article-title': 'Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin', 'volume': '215', 'author': 'Olson', 'year': '1980', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin by Olson (1980)
  42. 10.1016/0006-2952(92)90250-M / Biochem. Pharmacol. / Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine by Odom (1992)
  43. {'key': '10.1016/j.pcad.2006.10.002_bib43', 'first-page': '901', 'article-title': 'Repair kinetics of DNA, RNA and proteins in the tissues of mice treated with doxorubicin', 'volume': '29', 'author': 'Arena', 'year': '1979', 'journal-title': 'Arzneimittelforschung'} / Arzneimittelforschung / Repair kinetics of DNA, RNA and proteins in the tissues of mice treated with doxorubicin by Arena (1979)
  44. {'key': '10.1016/j.pcad.2006.10.002_bib44', 'first-page': '193', 'article-title': 'Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat', 'volume': '15', 'author': 'Monti', 'year': '1995', 'journal-title': 'Anticancer. Res.'} / Anticancer. Res. / Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat by Monti (1995)
  45. 10.1097/00005344-198009000-00002 / J. Cardiovasc. Pharmacol. / Acute and chronic cardiovascular effects of doxorubicin in the dog: The cardiovascular pharmacology of drug-induced histamine release by Bristow (1980)
  46. {'key': '10.1016/j.pcad.2006.10.002_bib46', 'first-page': 'H909', 'article-title': 'Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats', 'volume': '260', 'author': 'Tong', 'year': '1991', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats by Tong (1991)
  47. {'key': '10.1016/j.pcad.2006.10.002_bib47', 'first-page': '257', 'article-title': 'Inhibition of sodium-potassium-activated adenosine 5′-triphosphatase and ion transport by adriamycin', 'volume': '39', 'author': 'Gosalvez', 'year': '1979', 'journal-title': 'Cancer Res.'} / Cancer Res. / Inhibition of sodium-potassium-activated adenosine 5′-triphosphatase and ion transport by adriamycin by Gosalvez (1979)
  48. {'key': '10.1016/j.pcad.2006.10.002_bib48', 'first-page': 'H419', 'article-title': 'Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function', 'volume': '250', 'author': 'Singal', 'year': '1986', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function by Singal (1986)
  49. {'key': '10.1016/j.pcad.2006.10.002_bib49', 'first-page': '67', 'article-title': 'Direct effects of adriamycin on the rat heart sarcolemma', 'volume': '43', 'author': 'Singal', 'year': '1984', 'journal-title': 'Res. Commun. Chem. Pathol. Pharmacol.'} / Res. Commun. Chem. Pathol. Pharmacol. / Direct effects of adriamycin on the rat heart sarcolemma by Singal (1984)
  50. 10.1124/mol.61.3.516 / Mol. Pharmacol. / Multiple interference of anthracyclines with mitochondrial creatine kinases: Preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity by Tokarska-Schlattner (2002)
  51. {'key': '10.1016/j.pcad.2006.10.002_bib51', 'first-page': '439', 'article-title': 'Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits', 'volume': '77', 'author': 'Olson', 'year': '1974', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits by Olson (1974)
  52. 10.1038/sj.bjp.0704495 / Br. J. Pharmacol. / Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase by Mihm (2002)
  53. 10.1161/01.CIR.0000048192.52098.DD / Circulation / Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction by Pacher (2003)
  54. 10.1016/S0022-3565(24)39082-2 / J. Pharmacol. Exp. Ther. / Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice by Weinstein (2000)
  55. 10.1161/01.RES.84.3.257 / Circ. Res. / Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane by Sawyer (1999)
  56. 10.1074/jbc.M003890200 / J. Biol. Chem. / Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species by Kotamraju (2000)
  57. 10.1161/01.RES.83.5.516 / Circ. Res. / Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I by Wang (1998)
  58. 10.1161/01.RES.82.11.1111 / Circ. Res. / Apoptosis: Basic mechanisms and implications for cardiovascular disease by Haunstetter (1998)
  59. 10.1073/pnas.96.14.8144 / Proc. Natl. Acad. Sci. U. S. A. / Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy by Narula (1999)
  60. 10.1161/01.RES.86.11.1107 / Circ. Res. / Apoptosis and heart failure: A critical review of the literature by Kang (2000)
  61. 10.1006/jmcc.2000.1125 / J. Mol. Cell. Cardiol. / Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure by Elsasser (2000)
  62. 10.1111/j.1582-4934.2006.tb00291.x / J. Cell. Mol. Med. / Morphological aspects of apoptosis in heart diseases by Takemura (2006)
  63. {'key': '10.1016/j.pcad.2006.10.002_bib63', 'first-page': 'H2079', 'article-title': 'Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes', 'volume': '271', 'author': 'Sarvazyan', 'year': '1996', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes by Sarvazyan (1996)
  64. 10.1006/abbi.1999.1337 / Arch. Biochem. Biophys. / Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: The role of reactive oxygen and nitrogen intermediates by Konorev (1999)
  65. 10.1016/S0021-9258(17)35746-0 / J. Biol. Chem. / Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase by Davies (1986)
  66. 10.1016/S0021-9258(19)69315-4 / J. Biol. Chem. / Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen by Berlin (1981)
  67. 10.1073/pnas.76.2.954 / Proc. Natl. Acad. Sci. U. S. A. / NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals by Bachur (1979)
  68. 10.1172/JCI109642 / J. Clin. Invest. / Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin by Doroshow (1980)
  69. 10.1023/A:1014862912783 / Mol. Cell. Biochem. / Early changes in myocardial antioxidant enzymes in rats treated with adriamycin by Li (2002)
  70. 10.1016/0006-2952(85)90262-X / Biochem. Pharmacol. / Free radical production from normal and adriamycin-treated rat cardiac sarcosomes by Thornalley (1985)
  71. 10.1016/S0006-291X(88)81218-X / Biochem. Biophys. Res. Commun. / Direct detection of paramagnetic species in adriamycin perfused rat hearts by Costa (1988)
  72. 10.1021/bi00447a056 / Biochemistry / Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: A spin-trapping study by Alegria (1989)
  73. 10.1021/bi971475e / Biochemistry / Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin by Vasquez-Vivar (1997)
  74. 10.1074/jbc.M106829200 / J. Biol. Chem. / Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium by Kalivendi (2001)
  75. {'key': '10.1016/j.pcad.2006.10.002_bib75', 'first-page': '1929', 'article-title': 'Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents', 'volume': '59', 'author': 'Garner', 'year': '1999', 'journal-title': 'Cancer Res.'} / Cancer Res. / Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents by Garner (1999)
  76. {'key': '10.1016/j.pcad.2006.10.002_bib76', 'first-page': '276', 'article-title': 'Comparison of the effectiveness of (+/−)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles', 'volume': '45', 'author': 'Herman', 'year': '1985', 'journal-title': 'Cancer Res.'} / Cancer Res. / Comparison of the effectiveness of (+/−)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles by Herman (1985)
  77. 10.1056/NEJM198809223191203 / N. Engl. J. Med. / Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer by Speyer (1988)
  78. 10.1016/0305-7372(91)90015-R / Cancer Treat. Rev. / Toxicity profile of dexrazoxane (Zinecard, ICRF-187, ADR-529, NSC-169780), a modulator of doxorubicin cardiotoxicity by Curran (1991)
  79. 10.1177/106002809402800912 / Ann. Pharmacother. / Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity by Seifert (1994)
  80. {'key': '10.1016/j.pcad.2006.10.002_bib80', 'first-page': '1569', 'article-title': 'Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies', 'volume': '7', 'author': 'Tetef', 'year': '2001', 'journal-title': 'Clin. Cancer. Res.'} / Clin. Cancer. Res. / Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies by Tetef (2001)
  81. 10.1016/0092-8674(93)90046-S / Cell / Regulating the fate of mRNA: The control of cellular iron metabolism by Klausner (1993)
  82. 10.1006/abbi.1995.1019 / Arch. Biochem. Biophys. / Oxidative stress induces activation of a cytosolic protein responsible for control of iron uptake by Martins (1995)
  83. 10.1002/j.1460-2075.1995.tb07291.x / EMBO J. / Rapid responses to oxidative stress mediated by iron regulatory protein by Pantopoulos (1995)
  84. 10.1074/jbc.272.15.9802 / J. Biol. Chem. / Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress by Pantopoulos (1997)
  85. 10.1074/jbc.274.10.6219 / J. Biol. Chem. / Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinone-induced oxidative stress by Gehring (1999)
  86. 10.1016/S0968-0004(96)10024-4 / Trends Biochem. Sci. / Iron-sulfur clusters as biosensors of oxidants and iron by Rouault (1996)
  87. 10.1096/fasebj.13.2.199 / FASEB J. / Role of iron in anthracycline cardiotoxicity: New tunes for an old song? by Minotti (1999)
  88. 10.1200/JCO.2004.03.086 / J. Clin. Oncol. / Antioxidants and cancer therapy: A systematic review by Ladas (2004)
  89. 10.1128/MCB.14.7.4947 / Mol. Cell. Biol. / Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene by Molkentin (1994)
  90. 10.1042/bj3220393 / Biochem. J. / Regulation of the rat cardiac troponin I gene by the transcription factor GATA-4 by Murphy (1997)
  91. 10.1124/mol.63.2.368 / Mol. Pharmacol. / Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis by Kim (2003)
  92. 10.1073/pnas.0401833101 / Proc. Natl. Acad. Sci. U. S. A. / Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity by Aries (2004)
  93. 10.1152/ajpheart.01054.2004 / Am. J. Physiol. Heart Circ. Physiol. / Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy by Lou (2005)
  94. 10.1038/bjc.1972.33 / Br. J. Cancer. / Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics by Kerr (1972)
  95. 10.1038/284555a0 / Nature / Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation by Wyllie (1980)
  96. 10.1016/S0065-2776(08)60822-6 / Adv. Immunol. / Programmed cell death in the immune system by Cohen (1991)
  97. 10.1016/0140-6736(93)91154-E / Lancet / Apoptosis and disease by Carson (1993)
  98. 10.1083/jcb.119.3.493 / J. Cell. Biol. / Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation by Gavrieli (1992)
  99. 10.1083/jcb.135.5.1369 / J. Cell. Biol. / Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis by Didenko (1996)
  100. 10.1038/34112 / Nature / A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD by Enari (1998)
  101. 10.1038/sj.onc.1204141 / Oncogene / Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis by Fulda (2001)
  102. 10.1073/pnas.95.9.5156 / Proc. Natl. Acad. Sci. U. S. A. / ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases by Koseki (1998)
  103. 10.1074/jbc.272.30.18542 / J. Biol. Chem. / FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis by Srinivasula (1997)
  104. 10.1016/0092-8674(95)90071-3 / Cell / FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis by Chinnaiyan (1995)
  105. 10.1038/40901 / Nature / X-linked IAP is a direct inhibitor of cell-death proteases by Deveraux (1997)
  106. 10.1161/01.RES.81.2.137 / Circ. Res. / Death by design. Programmed cell death in cardiovascular biology and disease by MacLellan (1997)
  107. 10.1136/hrt.77.6.498 / Heart / Apoptosis in cardiovascular disease by Davies (1997)
  108. 10.1016/S0008-6363(99)00349-1 / Cardiovasc. Res. / Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction by Yaoita (2000)
  109. 10.1097/00001573-200005000-00011 / Curr. Opin. Cardiol. / Apoptosis and cardiomyopathy by Narula (2000)
  110. 10.1096/fj.01-0629com / FASEB J. / Losing heart: The role of apoptosis in heart disease—a novel therapeutic target? by Gill (2002)
  111. {'key': '10.1016/j.pcad.2006.10.002_bib111', 'first-page': '1789', 'article-title': 'Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis', 'volume': '60', 'author': 'Arola', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis by Arola (2000)
  112. 10.1016/0006-2952(88)90355-3 / Biochem. Pharmacol. / G2 block induced by DNA crosslinking agents and its possible consequences by Konopa (1988)
  113. 10.1152/ajpcell.2000.279.3.C868 / Am. J. Physiol. Cell. Physiol. / The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation by Wang (2000)
  114. 10.1074/jbc.M005366200 / J. Biol. Chem. / Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis by Huang (2000)
  115. 10.1126/science.275.5296.90 / Science / Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways by Ichijo (1997)
  116. 10.1126/science.270.5240.1326 / Science / Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis by Xia (1995)
  117. 10.1038/sj.emboj.7600194 / EMBO J. / JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins by Tsuruta (2004)
  118. 10.1002/path.1447 / J. Pathol. / Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? by Hughes (2003)
  119. 10.1002/path.1261 / J. Pathol. / Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: A manifestation of cardiac hypertrophy rather than failure by Koda (2003)
  120. 10.1161/01.CIR.99.21.2757 / Circulation / Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair by Kanoh (1999)
  121. 10.1159/000136248 / Pharmacology / A comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys by Herman (1971)
  122. 10.1007/s002800050453 / Cancer. Chemother. Pharmacol. / Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors by van Acker (1996)
  123. 10.1080/088800100276686 / Pediatr. Hematol. Oncol. / A longitudinal study of cardiac function in children with cancer over 40 months by Li (2000)
  124. 10.1067/mhj.2000.108237 / Am. Heart J. / Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines by Lanzarini (2000)
  125. 10.1200/JCO.1999.17.10.3207 / J. Clin. Oncol. / Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence by Green (1999)
  126. 10.1016/0002-9343(77)90315-1 / Am. J. Med. / Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases by Von Hoff (1977)
  127. 10.1007/s002800050926 / Cancer Chemother. Pharmacol. / Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: The M.D. Anderson experience by Ibrahim (1999)
  128. 10.1002/1097-0142(19820701)50:1<32::AID-CNCR2820500108>3.0.CO;2-Q / Cancer / Efficacy and cost of cardiac monitoring in patients receiving doxorubicin by Bristow (1982)
  129. 10.1016/0002-9343(87)90212-9 / Am. J. Med. / Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography by Schwartz (1987)
  130. {'key': '10.1016/j.pcad.2006.10.002_bib130', 'first-page': '857', 'article-title': 'Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: Superiority of histopathologic assessment using endomyocardial biopsy', 'volume': '62', 'author': 'Mason', 'year': '1978', 'journal-title': 'Cancer Treat. Rep.'} / Cancer Treat. Rep. / Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: Superiority of histopathologic assessment using endomyocardial biopsy by Mason (1978)
  131. 10.1016/0002-8703(81)90096-X / Am. Heart J. / Dose-effect and structure-function relationships in doxorubicin cardiomyopathy by Bristow (1981)
  132. 10.7326/0003-4819-99-6-745 / Ann. Intern. Med. / Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy by Torti (1983)
  133. 10.1159/000227621 / Oncology / Review of tests for monitoring doxorubicin-induced cardiomyopathy by Ganz (1996)
  134. 10.1016/0002-8703(83)90651-8 / Am. Heart J. / Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity by McKillop (1983)
  135. 10.1056/NEJM197902083000603 / N. Engl. J. Med. / Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography by Alexander (1979)
  136. 10.7326/0003-4819-94-4-430 / Ann. Intern. Med. / Doxorubicin cardiotoxicity: Assessment of late left ventricular dysfunction by radionuclide cineangiography by Gottdiener (1981)
  137. {'key': '10.1016/j.pcad.2006.10.002_bib137', 'first-page': '1620', 'article-title': 'Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function', 'volume': '28', 'author': 'Sisson', 'year': '1987', 'journal-title': 'J. Nucl. Med.'} / J. Nucl. Med. / Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function by Sisson (1987)
  138. 10.1002/1097-0142(19850701)56:1<76::AID-CNCR2820560113>3.0.CO;2-S / Cancer / Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography by Piver (1985)
  139. 10.1007/BF02258455 / Eur. J. Nucl. Med. / Clinical role of indium-111 antimyosin imaging by Bhattacharya (1991)
  140. {'key': '10.1016/j.pcad.2006.10.002_bib140', 'first-page': '1283', 'article-title': 'Metaiodobenzylguanidine: Evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy', 'volume': '34', 'author': 'Wakasugi', 'year': '1993', 'journal-title': 'J. Nucl. Med.'} / J. Nucl. Med. / Metaiodobenzylguanidine: Evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy by Wakasugi (1993)
  141. {'key': '10.1016/j.pcad.2006.10.002_bib141', 'first-page': '1529', 'article-title': 'Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy', 'volume': '34', 'author': 'Wakasugi', 'year': '1993', 'journal-title': 'J. Nucl. Med.'} / J. Nucl. Med. / Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy by Wakasugi (1993)
  142. 10.1161/01.CIR.86.6.1965 / Circulation / Myocardial uptake of 111In monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats. Morphological and hemodynamic findings by Hiroe (1992)
  143. {'key': '10.1016/j.pcad.2006.10.002_bib143', 'first-page': '1965', 'article-title': 'Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer', 'volume': '31', 'author': 'Estorch', 'year': '1990', 'journal-title': 'J. Nucl. Med.'} / J. Nucl. Med. / Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer by Estorch (1990)
  144. 10.1182/blood.V84.5.1415.bloodjournal8451415 / Blood / Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis by Koopman (1994)
  145. 10.1073/pnas.95.11.6349 / Proc. Natl. Acad. Sci. U. S. A. / In vivo detection and imaging of phosphatidylserine expression during programmed cell death by Blankenberg (1998)
  146. {'key': '10.1016/j.pcad.2006.10.002_bib146', 'first-page': '842', 'article-title': 'Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats', 'volume': '45', 'author': 'Bennink', 'year': '2004', 'journal-title': 'J. Nucl. Med.'} / J. Nucl. Med. / Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats by Bennink (2004)
  147. 10.1126/science.2935937 / Science / Atrial natriuretic peptide elevation in congestive heart failure in the human by Burnett (1986)
  148. 10.1056/NEJM199009133231114 / N. Engl. J. Med. / Increased human brain natriuretic peptide in congestive heart failure by Mukoyama (1990)
  149. 10.1002/mpo.1155 / Med. Pediatr. Oncol. / Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer by Hayakawa (2001)
  150. 10.1053/hj.1998.v136.89908 / Am. Heart J. / Elevated B-type natriuretic peptide levels after anthracycline administration by Suzuki (1998)
  151. 10.1038/sj.bmt.1703132 / Bone Marrow Transplant / Serum cardiac troponin I levels and ECG/echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide by Morandi (2001)
  152. 10.1002/cncr.11407 / Cancer / Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials by Swain (2003)
  153. 10.1002/1097-0142(19900215)65:4<870::AID-CNCR2820650407>3.0.CO;2-D / Cancer / Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation by Shapira (1990)
  154. 10.7326/0003-4819-96-2-133 / Ann. Intern. Med. / Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion by Legha (1982)
  155. 10.1016/0002-9343(85)90395-X / Am. J. Med. / Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast by Speyer (1985)
  156. 10.1016/0277-5379(89)90135-1 / Eur. J. Cancer. Clin. Oncol. / Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy by Bielack (1989)
  157. 10.1093/jnci/82.21.1706 / J. Natl. Cancer. Inst. / Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: Phase II study by Treat (1990)
  158. 10.1053/j.seminoncol.2004.08.010 / Semin. Oncol. / Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials by Alberts (2004)
  159. 10.1016/0041-008X(79)90284-9 / Toxicol. Appl. Pharmacol. / The effects of alpha-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice by Mimnaugh (1979)
  160. 10.1111/j.1600-0773.1986.tb00066.x / Acta. Pharmacol. Toxicol. (Copenh) / The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in mice by Hermansen (1986)
  161. {'key': '10.1016/j.pcad.2006.10.002_bib161', 'first-page': '13', 'article-title': 'Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants', 'volume': '99', 'author': 'Van Vleet', 'year': '1980', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants by Van Vleet (1980)
  162. 10.1016/0006-2952(92)90427-K / Biochem. Pharmacol. / PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity by Pritsos (1992)
  163. {'key': '10.1016/j.pcad.2006.10.002_bib163', 'first-page': '735', 'article-title': 'Intervention of adriamycin induced free radical damage', 'volume': '28', 'author': 'Balanehru', 'year': '1992', 'journal-title': 'Biochem. Int.'} / Biochem. Int. / Intervention of adriamycin induced free radical damage by Balanehru (1992)
  164. 10.1016/0891-5849(95)00028-V / Free Radic. Biol. Med. / Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice by Nowak (1995)
  165. 10.1161/01.CIR.89.6.2829 / Circulation / Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats by Siveski-Iliskovic (1994)
  166. 10.1007/s00280-003-0676-y / Cancer Chemother. Pharmacol. / New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity by El-Demerdash (2003)
  167. 10.1016/S0024-3205(99)00362-8 / Life Sci. / Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats by Matsui (1999)
  168. 10.1016/S0033-0620(98)80027-3 / Prog. Cardiovasc. Dis. / Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol by Feuerstein (1998)
  169. 10.1016/j.taap.2004.04.005 / Toxicol. Appl. Pharmacol. / Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity by Oliveira (2004)
  170. 10.1002/clc.4960211017 / Clin. Cardiol. / Doxorubicin-induced cardiomyopathy treated with carvedilol by Fazio (1998)
  171. 10.1006/taap.2002.9532 / Toxicol. Appl. Pharmacol. / Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy by Santos (2002)
  172. {'key': '10.1016/j.pcad.2006.10.002_bib172', 'first-page': '2307', 'article-title': "dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin", 'volume': '50', 'author': 'Vile', 'year': '1990', 'journal-title': 'Cancer Res.'} / Cancer Res. / dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin by Vile (1990)
  173. {'key': '10.1016/j.pcad.2006.10.002_bib173', 'first-page': '3436', 'article-title': 'Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/−)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187)', 'volume': '41', 'author': 'Herman', 'year': '1981', 'journal-title': 'Cancer Res.'} / Cancer Res. / Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/−)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) by Herman (1981)
  174. {'key': '10.1016/j.pcad.2006.10.002_bib174', 'first-page': '249', 'article-title': 'Phase I study of ICRF-187 using a daily for 3 days schedule', 'volume': '65', 'author': 'Von Hoff', 'year': '1981', 'journal-title': 'Cancer. Treat. Rep.'} / Cancer. Treat. Rep. / Phase I study of ICRF-187 using a daily for 3 days schedule by Von Hoff (1981)
  175. 10.1200/JCO.2002.04.178 / J. Clin. Oncol. / American Society of Clinical Oncology Chemotherapy and Radiotherapy Expert Panel by Schuchter (2002)
  176. 10.1161/CIRCULATIONAHA.105.568402 / Circulation / Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy by Li (2006)
  177. 10.1007/s10557-006-7652-9 / Cardiovasc. Drugs Ther. / Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats by Hou (2006)
  178. 10.1161/CIRCULATIONAHA.105.560250 / Circulation / Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin by Li (2006)
  179. 10.2165/00003495-199400474-00006 / Drugs / The role of beta-blockers in the treatment of cardiomyopathy and ischaemic heart failure by Hjalmarson (1994)
  180. 10.1016/0002-8703(95)90061-6 / Am. Heart J. / Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients by Shaddy (1995)
  181. {'key': '10.1016/j.pcad.2006.10.002_bib181', 'first-page': '815', 'article-title': 'Orthotopic heart transplantation: An efficient treatment in a young boy with doxorubicin-induced cardiomyopathy', 'volume': '11', 'author': 'Luthy', 'year': '1992', 'journal-title': 'J. Heart Lung Transplant'} / J. Heart Lung Transplant / Orthotopic heart transplantation: An efficient treatment in a young boy with doxorubicin-induced cardiomyopathy by Luthy (1992)
  182. 10.1056/NEJM198811173192014 / N. Engl. J. Med. / Heart transplantation in a child with doxorubicin-induced cardiomyopathy by Arico (1988)
  183. 10.1007/s00277-002-0534-8 / Ann. Hematol. / Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia by Thomas (2002)
  184. 10.1056/NEJM199809243391307 / N. Engl. J. Med. / Doxorubicin-induced cardiomyopathy by Singal (1998)
  185. 10.1096/fasebj.11.12.9337145 / FASEB J. / Adriamycin cardiomyopathy: Pathophysiology and prevention by Singal (1997)
  186. 10.1023/A:1015976430790 / Mol. Cell Biochem. / Doxorubicin-induced apoptosis: Implications in cardiotoxicity by Kalyanaraman (2002)
Dates
Type When
Created 18 years, 6 months ago (Feb. 28, 2007, 7:30 a.m.)
Deposited 7 months, 2 weeks ago (Jan. 14, 2025, 4:46 a.m.)
Indexed 59 minutes ago (Aug. 28, 2025, 6:18 p.m.)
Issued 18 years, 5 months ago (March 1, 2007)
Published 18 years, 5 months ago (March 1, 2007)
Published Print 18 years, 5 months ago (March 1, 2007)
Funders 0

None

@article{Takemura_2007, title={Doxorubicin-Induced Cardiomyopathy}, volume={49}, ISSN={0033-0620}, url={http://dx.doi.org/10.1016/j.pcad.2006.10.002}, DOI={10.1016/j.pcad.2006.10.002}, number={5}, journal={Progress in Cardiovascular Diseases}, publisher={Elsevier BV}, author={Takemura, Genzou and Fujiwara, Hisayoshi}, year={2007}, month=mar, pages={330–352} }